This biotech’s versatility could see it age like fine wine
Universal Biosensors (ASX:UBI) is well into commercial phase and is thus ‘grown up’, but chairman Graham McLean acknowledges the company has struggled to reach adulthood and produce consistent returns. “Progress has always been slower than expected,” he …